Aveo Pharmaceuticals, Inc.
AVEODelisted Jan 19, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001325879
Aveo Pharmaceuticals, Inc. was delisted on Jan 19, 2023; its insiders filed their last Form 4 on Jan 19, 2023; 110 institutions reported holding it in 13F filings for Q4 2022, worth $367.6M in total; no superinvestor held it.
Q4 2021 vs. Q3 2021
How the institutions holding Aveo Pharmaceuticals, Inc. changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Q4 2021 | Change |
|---|---|---|---|
| Holders | 51 | 57 | +6 |
| Shares | 15.0M | 15.4M | +418.8K (+2.8%) |
| Value | $92.7M | $72.3M | −$20.4M (−22.0%) |
New holders (12)
Institutions that held Aveo Pharmaceuticals, Inc. at the end of Q4 2021 but not at the end of Q3 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Sender Co & Partners, Inc. | 92,026 | $432.0K | 0.28% |
| D. E. Shaw & Co., Inc. | 39,298 | $184.0K | 0.00% |
| Jump Financial, LLC | 24,181 | $113.0K | 0.01% |
| XTX Topco Ltd | 18,128 | $85.0K | 0.05% |
| Shay Capital LLC | 13,243 | $62.0K | 0.02% |
| ExodusPoint Capital Management, LP | 11,264 | $53.0K | 0.00% |
| Lazard Asset Management LLC | 7,542 | $35.0K | 0.00% |
| Steward Financial Group LLC | 2,000 | $9.00K | 0.01% |
| CarsonAllaria Wealth Management, Ltd. | 1,490 | $7.00K | 0.01% |
| Magnolia Capital Management Ltd | 1,000 | $5.00K | 0.00% |
| National Bank of Canada | 100 | $0 | 0.00% |
| Andrew Hill Investment Advisors, Inc. | 10 | $0 | 0.00% |
Sold out (6)
Institutions that held Aveo Pharmaceuticals, Inc. at the end of Q3 2021 and filed for Q4 2021 without it.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Gsa Capital Partners LLP | 35,232 | $218.0K |
| Cubist Systematic Strategies, LLC | 33,548 | $207.0K |
| Connor, Clark & Lunn Investment Management Ltd. | 14,742 | $91.0K |
| Bank of New York Mellon Corp | 12,564 | $78.0K |
| Virtu Financial LLC | 10,342 | $64.0K |
| Golden State Wealth Management, LLC | 500 | $3.00K |